MoonLake Immunotherapeutics — reported holders

6 institutional managers with a reported position

This is history, not a current position. Each row is what a manager reported for the quarter shown, published up to 45 days after that quarter ended.

Aggregates

computed from the rows below
Managers reporting
6
Combined reported value
$11.4M
Top 5 concentration
99.9%
Median position
$577.8K
Largest position
$7.3M
Quarters represented
1
managers file on different schedules
Most recent quarter
2026Q2
Managers reporting shares
6
ManagerQuarterValueSharesFiled
Capricorn Fund Managers Ltd2026Q2$7.3M374,8662026-07-24
CONGRESS ASSET MANAGEMENT CO2026Q2$3.5M180,4482026-07-07
Campbell & CO Investment Adviser LLC2026Q2$577.8K29,6782026-08-03
CITIGROUP INC2026Q2$26.4K1,3582026-08-03
Farther Finance Advisors, LLC2026Q2$17.3K8832026-07-17
Caitong International Asset Management Co., Ltd2026Q2$10.8K5532026-08-05

Source: U.S. Securities and Exchange Commission, Form 13F

MoonLake Immunotherapeutics — reported by 6 institutional managers — Tapewire